HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$2.05
Day range
$2.09 - $2.12
Year range
$0.81 - $2.35
Market cap
50.78M USD
Avg Volume
5.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.89M | -70.71% |
Net income | -6.09M | -57.18% |
Net profit margin | — | — |
Earnings per share | -0.24 | 80.00% |
EBITDA | -4.88M | 69.97% |
Effective tax rate | -2.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.50M | -59.60% |
Total assets | 15.92M | -59.92% |
Total liabilities | 27.43M | -24.42% |
Total equity | -11.51M | — |
Shares outstanding | 27.52M | — |
Price to book | -4.02 | — |
Return on assets | -81.18% | — |
Return on capital | -111.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.09M | -57.18% |
Cash from operations | -2.67M | 71.16% |
Cash from investing | 5.70M | 1,483.33% |
Cash from financing | 5.43M | 54,200.00% |
Net change in cash | 8.43M | 194.53% |
Free cash flow | 1.09M | 130.67% |
About
Founded
2015
Website
Employees
14
